The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas

Yoriyoshi Kimurau, Hisashi Koga, Norie Araki, Norifumi Mugita, Naoyuki Fujita, Hideo Takeshima, Tohru Nishi, Tetsumori Yamashima, Takaomi C. Saido, Toshiki Yamasaki, Kouzo Moritake, Hideyuki Saya, Mitsuyoshi Nakao

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Neurofibromatosis type 2 (NF2) protein, also known as merlin or schwannomin, is a tumor suppressor, and NF2 is mutated in most schwannomas and meningiomas. Although these tumors are dependent on NF2, some lack detectable NF2 mutations, which indicates that alternative mechanisms exist for inactivating merlin. Here, we demonstrate cleavage of merlin by the ubiquitous protease calpain and considerable activation of the calpain system resulting in the loss of merlin expression in these tumors. Increased proteolysis of merlin by calpain in some schwannomas and meningiomas exemplifies tumorigenesis linked to the calpain-mediated proteolytic pathway.

Original languageEnglish
Pages (from-to)915-922
Number of pages8
JournalNature Medicine
Volume4
Issue number8
DOIs
Publication statusPublished - 1998 Aug
Externally publishedYes

Fingerprint

Neurofibromin 2
Proteolysis
Neurofibromatosis 2
Calpain
Neurilemmoma
Meningioma
Tumors
Neoplasms
oleoyl-estrone
Carcinogenesis
Peptide Hydrolases
Chemical activation
Mutation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Kimurau, Y., Koga, H., Araki, N., Mugita, N., Fujita, N., Takeshima, H., ... Nakao, M. (1998). The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas. Nature Medicine, 4(8), 915-922. https://doi.org/10.1038/nm0898-915

The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas. / Kimurau, Yoriyoshi; Koga, Hisashi; Araki, Norie; Mugita, Norifumi; Fujita, Naoyuki; Takeshima, Hideo; Nishi, Tohru; Yamashima, Tetsumori; Saido, Takaomi C.; Yamasaki, Toshiki; Moritake, Kouzo; Saya, Hideyuki; Nakao, Mitsuyoshi.

In: Nature Medicine, Vol. 4, No. 8, 08.1998, p. 915-922.

Research output: Contribution to journalArticle

Kimurau, Y, Koga, H, Araki, N, Mugita, N, Fujita, N, Takeshima, H, Nishi, T, Yamashima, T, Saido, TC, Yamasaki, T, Moritake, K, Saya, H & Nakao, M 1998, 'The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas', Nature Medicine, vol. 4, no. 8, pp. 915-922. https://doi.org/10.1038/nm0898-915
Kimurau, Yoriyoshi ; Koga, Hisashi ; Araki, Norie ; Mugita, Norifumi ; Fujita, Naoyuki ; Takeshima, Hideo ; Nishi, Tohru ; Yamashima, Tetsumori ; Saido, Takaomi C. ; Yamasaki, Toshiki ; Moritake, Kouzo ; Saya, Hideyuki ; Nakao, Mitsuyoshi. / The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas. In: Nature Medicine. 1998 ; Vol. 4, No. 8. pp. 915-922.
@article{277b17868bcd4682b9f4fb3e9e08eaff,
title = "The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas",
abstract = "Neurofibromatosis type 2 (NF2) protein, also known as merlin or schwannomin, is a tumor suppressor, and NF2 is mutated in most schwannomas and meningiomas. Although these tumors are dependent on NF2, some lack detectable NF2 mutations, which indicates that alternative mechanisms exist for inactivating merlin. Here, we demonstrate cleavage of merlin by the ubiquitous protease calpain and considerable activation of the calpain system resulting in the loss of merlin expression in these tumors. Increased proteolysis of merlin by calpain in some schwannomas and meningiomas exemplifies tumorigenesis linked to the calpain-mediated proteolytic pathway.",
author = "Yoriyoshi Kimurau and Hisashi Koga and Norie Araki and Norifumi Mugita and Naoyuki Fujita and Hideo Takeshima and Tohru Nishi and Tetsumori Yamashima and Saido, {Takaomi C.} and Toshiki Yamasaki and Kouzo Moritake and Hideyuki Saya and Mitsuyoshi Nakao",
year = "1998",
month = "8",
doi = "10.1038/nm0898-915",
language = "English",
volume = "4",
pages = "915--922",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas

AU - Kimurau, Yoriyoshi

AU - Koga, Hisashi

AU - Araki, Norie

AU - Mugita, Norifumi

AU - Fujita, Naoyuki

AU - Takeshima, Hideo

AU - Nishi, Tohru

AU - Yamashima, Tetsumori

AU - Saido, Takaomi C.

AU - Yamasaki, Toshiki

AU - Moritake, Kouzo

AU - Saya, Hideyuki

AU - Nakao, Mitsuyoshi

PY - 1998/8

Y1 - 1998/8

N2 - Neurofibromatosis type 2 (NF2) protein, also known as merlin or schwannomin, is a tumor suppressor, and NF2 is mutated in most schwannomas and meningiomas. Although these tumors are dependent on NF2, some lack detectable NF2 mutations, which indicates that alternative mechanisms exist for inactivating merlin. Here, we demonstrate cleavage of merlin by the ubiquitous protease calpain and considerable activation of the calpain system resulting in the loss of merlin expression in these tumors. Increased proteolysis of merlin by calpain in some schwannomas and meningiomas exemplifies tumorigenesis linked to the calpain-mediated proteolytic pathway.

AB - Neurofibromatosis type 2 (NF2) protein, also known as merlin or schwannomin, is a tumor suppressor, and NF2 is mutated in most schwannomas and meningiomas. Although these tumors are dependent on NF2, some lack detectable NF2 mutations, which indicates that alternative mechanisms exist for inactivating merlin. Here, we demonstrate cleavage of merlin by the ubiquitous protease calpain and considerable activation of the calpain system resulting in the loss of merlin expression in these tumors. Increased proteolysis of merlin by calpain in some schwannomas and meningiomas exemplifies tumorigenesis linked to the calpain-mediated proteolytic pathway.

UR - http://www.scopus.com/inward/record.url?scp=0031902117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031902117&partnerID=8YFLogxK

U2 - 10.1038/nm0898-915

DO - 10.1038/nm0898-915

M3 - Article

VL - 4

SP - 915

EP - 922

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 8

ER -